Invacare Corporation (IVC)
NYSE: IVC
· Real-Time Price · USD
0.66
-0.02 (-2.22%)
At close: Jan 31, 2023, 10:00 PM
Invacare Revenue Breakdown
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| All Other Revenue | 8.19M | 7.74M | 7.61M | 7.53M | 7.59M | 7.46M | 9.12M | 8.32M | 7.45M |
| All Other Revenue Growth | +5.84% | +1.77% | +1.01% | -0.78% | +1.67% | -18.15% | +9.60% | +11.65% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| All Other Revenue | 1.32M | 102.97M | 2.76M | 3.29M | 2.81M | 134.51M | 1.33M | 1.28M | 1.27M |
| All Other Revenue Growth | -98.72% | +3625.51% | -15.96% | +16.88% | -97.91% | +9998.35% | +4.31% | +0.16% | n/a |
| Europe (Emea) Revenue | 3.05M | 66.73M | 65.07M | 68.53M | 75.18M | 80.65M | 3.35M | 3.13M | 2.93M |
| Europe (Emea) Revenue Growth | -95.43% | +2.56% | -5.04% | -8.86% | -6.77% | +2303.76% | +7.15% | +6.82% | n/a |
| North America (Na) Revenue | 51.91M | 6.53M | 1.23M | 1.23M | 1.21M | 6.21M | 87.94M | 95.98M | 75.7M |
| North America (Na) Revenue Growth | +695.49% | +431.78% | +0.08% | +1.49% | -80.55% | -92.94% | -8.39% | +26.79% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 53.81M | 52.23M | 55.37M | 58.62M | 60.56M | 53.52M | 56.13M | 63.77M | 58.82M | 61.69M | 55.53M | 57.4M | 61.74M | 63.03M | 63.54M | 68.25M | 65.24M | 66.93M | 69.94M | 73.76M | 71.26M | 72.66M | 75.92M | 75.72M | 72.51M | 74.52M | 77.7M | 78.72M | 73.21M | 78.48M | 77.58M | 82.55M | 81.24M |
| Selling, General, and Administrative Revenue Growth | +3.03% | -5.67% | -5.56% | -3.20% | +13.16% | -4.66% | -11.97% | +8.41% | -4.64% | +11.08% | -3.26% | -7.02% | -2.04% | -0.81% | -6.91% | +4.62% | -2.53% | -4.30% | -5.18% | +3.51% | -1.92% | -4.29% | +0.26% | +4.42% | -2.69% | -4.10% | -1.29% | +7.52% | -6.72% | +1.17% | -6.02% | +1.61% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |